In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott acquires Alza in $7.3bn stock swap; withdrawn

Executive Summary

Abbott Laboratories has agreed to acquire pharmaceutical and drug delivery company Alza Corp. in a $7.3bn stock swap. The deal provides Alza stockholders with 1.2 Abbott common shares (selling at an average of $44.1 apiece the 10 days before announcement) for each Alza common share (about 135mm outstanding).
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies